Matthews International Capital Management LLC Bei Gene, Ltd. Transaction History

Matthews International Capital Management LLC

$468 Million
Q4 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 17, 2024	SELL	$158.67 - $201.58 $6.34 Million - $8.06 Million	-39,988 Reduced 65.67%	20,902 $3.77 Million
Q3 2023 Oct 27, 2023	SELL	$179.87 - $225.13 $12 Million - $15 Million	-66,847 Reduced 52.33%	60,890 $11 Million
Q2 2023 Aug 10, 2023	SELL	$178.3 - $266.78 $1.64 Million - $2.46 Million	-9,221 Reduced 6.73%	127,737 $22.8 Million
Q1 2023 May 10, 2023	BUY	$215.53 - $274.5 $2.98 Million - $3.8 Million	13,831 Added 11.23%	136,958 $29.5 Million
Q4 2022 Feb 09, 2023	SELL	$125.51 - $229.3 $4.94 Million - $9.03 Million	-39,373 Reduced 24.23%	123,127 $27.1 Million
Q3 2022 Nov 04, 2022	SELL	$131.8 - $202.24 $1.99 Million - $3.05 Million	-15,092 Reduced 8.5%	162,500 $21.9 Million
Q1 2022 May 05, 2022	SELL	$146.52 - $269.56 $8.09 Million - $14.9 Million	-55,200 Reduced 23.71%	177,592 $33.5 Million
Q4 2021 Feb 02, 2022	SELL	$248.56 - $389.34 $2.91 Million - $4.56 Million	-11,700 Reduced 4.79%	232,792 $63.1 Million
Q3 2021 Nov 08, 2021	BUY	$249.6 - $403.14 $199,680 - $322,512	800 Added 0.33%	244,492 $88.8 Million
Q2 2021 Aug 10, 2021	BUY	$292.75 - $367.01 $58,550 - $73,402	200 Added 0.08%	243,692 $83.6 Million
Q1 2021 May 06, 2021	BUY	$260.64 - $382.12 $7.53 Million - $11 Million	28,900 Added 13.47%	243,492 $84.8 Million
Q4 2020 Feb 09, 2021	SELL	$221.31 - $316.61 $221,310 - $316,610	-1,000 Reduced 0.46%	214,592 $55.4 Million
Q3 2020 Nov 05, 2020	SELL	$189.18 - $286.44 $6.05 Million - $9.17 Million	-32,000 Reduced 12.92%	215,592 $61.8 Million
Q2 2020 Jul 29, 2020	SELL	$123.9 - $195.41 $3.02 Million - $4.77 Million	-24,400 Reduced 8.97%	247,592 $46.6 Million
Q1 2020 May 11, 2020	BUY	$121.84 - $173.19 $7.46 Million - $10.6 Million	61,189 Added 29.03%	271,992 $33.5 Million
Q4 2019 Feb 04, 2020	BUY	$115.78 - $208.34 $2.63 Million - $4.73 Million	22,700 Added 12.07%	210,803 $34.9 Million
Q3 2019 Nov 05, 2019	SELL	$120.61 - $148.29 $13.5 Million - $16.6 Million	-112,200 Reduced 37.36%	188,103 $23 Million
Q2 2019 Aug 06, 2019	BUY	$113.99 - $146.86 $7.6 Million - $9.8 Million	66,700 Added 28.55%	300,303 $37.2 Million
Q1 2019 May 06, 2019	SELL	$122.82 - $151.83 $1.2 Million - $1.49 Million	-9,800 Reduced 4.03%	233,603 $30.8 Million
Q4 2018 Feb 06, 2019	BUY	$107.01 - $175.15 $3.88 Million - $6.36 Million	36,300 Added 17.53%	243,403 $34.1 Million
Q3 2018 Nov 14, 2018	BUY	$152.62 - $189.66 $4.91 Million - $6.11 Million	32,200 Added 18.41%	207,103 $35.7 Million
Q2 2018 Aug 13, 2018	BUY	$152.5 - $216.77 $7.87 Million - $11.2 Million	51,600 Added 41.85%	174,903 $26.9 Million
Q1 2018 May 10, 2018	BUY	$97.41 - $177.22 $12 Million - $21.9 Million	123,303 New	123,303 $20.7 Million

Others Institutions Holding BGNE

# of Institutions

251

Shares Held

45.3M

Call Options Held

292K

Put Options Held

119K

Baker Bros. Advisors LP New York, NY

10.6M
Shares

$2.4 Billion
25.41% of portfolio
Capital International Investors Los Angeles, CA

6.43M
Shares

$1.46 Billion
0.29% of portfolio
Hhlr Advisors, Ltd. Grand Cayman, E9

5.18M
Shares

$1.17 Billion
26.65% of portfolio
Primecap Management CO Pasadena, CA

4.97M
Shares

$1.13 Billion
0.84% of portfolio
Baillie Gifford & CO

3.67M
Shares

$832 Million
0.54% of portfolio

View Full List

About BeiGene, Ltd.

Ticker BGNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 103,700,000
Market Cap $23.5B
Description
BeiGene, Ltd., a biotechnology company, focuses on discovering, developing, manufacturing, and commercializing various medicines worldwide. Its products include BRUKINSA to treat relapsed/refractory (R/R) mantle cell lymphoma; Tislelizumab to treat R/R classical Hodgkin's lymphoma; REVLIMID to treat multiple myeloma; VIDAZA to treat myelodysplas...

More about BGNE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Matthews International Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Matthews International Capital Management LLC with notifications on news.

Account